000 01626 a2200445 4500
005 20250515115453.0
264 0 _c20090109
008 200901s 0 0 eng d
022 _a1476-5500
024 7 _a10.1038/cgt.2008.18
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSas, S
245 0 0 _aVaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
_h[electronic resource]
260 _bCancer gene therapy
_cOct 2008
300 _a655-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
_ximmunology
650 0 4 _aCancer Vaccines
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFlow Cytometry
650 0 4 _aGenes, erbB-2
_xgenetics
650 0 4 _aGenetic Vectors
_xgenetics
650 0 4 _aMale
650 0 4 _aMammary Neoplasms, Animal
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
700 1 _aChan, T
700 1 _aSami, A
700 1 _aEl-Gayed, A
700 1 _aXiang, J
773 0 _tCancer gene therapy
_gvol. 15
_gno. 10
_gp. 655-66
856 4 0 _uhttps://doi.org/10.1038/cgt.2008.18
_zAvailable from publisher's website
999 _c17918977
_d17918977